Goosehead Insurance grants 13,979 director options
Goosehead Insurance, Inc. director Cruzado Waded received a grant of 13,979 Director Stock Options on Class A Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Goosehead Insurance, Inc. director Cruzado Waded received a grant of 13,979 Director Stock Options on Class A Common Stock. The options have an exercise price of $42.46 per share and expire on May 5, 2036.
The grant vests in 12 equal quarterly installments over three years, subject to continued service, with all options vesting early upon a defined change in control. After this award, the director holds 13,979 options directly.
Insider Trade Summary
Grant/Award: 13,979 shares
Grant/Award
1 txn
Insider
Cruzado Waded
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Options (right to buy) | 13,979 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Options (right to buy) — 13,979 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date; provided that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the Issuer's Amended and Restated Omnibus Incentive Plan).
Key Figures
Options granted: 13,979 options
Exercise price: $42.46 per share
Expiration date: May 5, 2036
+3 more
6 metrics
Options granted
13,979 options
Director Stock Options granted on May 5, 2026
Exercise price
$42.46 per share
Exercise price for Director Stock Options
Expiration date
May 5, 2036
Option expiration for director grant
Underlying shares
13,979 shares
Class A Common Stock underlying granted options
Post-grant option holdings
13,979 options
Total Director Stock Options held after transaction
Vesting schedule
12 quarterly installments over 3 years
Vesting of director option grant, subject to continued service
Key Terms
Director Stock Options (right to buy), Class A Common Stock, change in control, Amended and Restated Omnibus Incentive Plan, +1 more
5 terms
Director Stock Options (right to buy) financial
"security_title: Director Stock Options (right to buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
change in control financial
"will vest and become exercisable upon a "change in control""
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated Omnibus Incentive Plan financial
"as defined in the Issuer's Amended and Restated Omnibus Incentive Plan"
quarterly installments financial
"shall vest and become exercisable ... in 12 equal quarterly installments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Goosehead Insurance (GSHD) director Cruzado Waded report on this Form 4?
Cruzado Waded reported receiving a grant of 13,979 Director Stock Options. These options relate to Goosehead Insurance Class A Common Stock and represent a compensation award rather than an open-market stock purchase or sale by the director.
What are the key terms of Cruzado Waded’s Goosehead Insurance stock option grant?
The award covers 13,979 Director Stock Options with an exercise price of $42.46 per share. The options are exercisable into Goosehead Insurance Class A Common Stock and expire on May 5, 2036, if not earlier exercised or forfeited under plan terms.
How do the Goosehead Insurance director stock options vest for Cruzado Waded?
The 13,979 options vest in 12 equal quarterly installments over three years, conditioned on continued service. This means a portion becomes exercisable every quarter, gradually increasing the director’s exercisable options position during the vesting period.
Is there accelerated vesting for Cruzado Waded’s Goosehead Insurance options?
Yes. All shares subject to the option will vest and become exercisable upon a “change in control” as defined in Goosehead Insurance’s Amended and Restated Omnibus Incentive Plan, accelerating the vesting schedule if such a corporate event occurs.
How many Goosehead Insurance options does Cruzado Waded hold after this transaction?
Following the reported grant, Cruzado Waded holds 13,979 Director Stock Options directly. This total matches the number of options awarded in the transaction, indicating the position reported in this filing is entirely from this new grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
